Lymphoma Video Perspectives

Jing-Zhou Hou, MD, PhD

Hou reports being on advisory boards for AbbVie, AstraZeneca and Genentech, and receiving research funding from AstraZeneca. He also reports being a principal investigator in lymphoma studies sponsored by AbbVie and Genentech.
June 16, 2023
3 min watch
Save

VIDEO: Complimentary and alternative therapies for lymphoma

Transcript

Editor’s note: This is a previously posted video, and the below is an automatically generated transcript to be used for informational purposes. Please notify cperla@healio.com if there are concerns regarding accuracy of the transcription.

This is an area lack of strong clinical evidence to either support or not support this area. And I mean, clearly, a study need to be done. But in general, what I see for this area of complementary medicine, either alternative medicine either by taking an oral agent or other method. I think that there's values. For example, when we treat patient as oncologists, we're primarily considering three medium and chemotherapy radiation surgery. We focus on primarily on the tumor and a patient's physical body. And sometime we pay attention to the mind or how patients feels emotionally and this, however, as a oncologist, I think we are now trained to intervene the mental health issues. But this is an area that the alternative medicine can play a role to help the patient to cope with that. Some like yoga or some meditation will be helpful, and in addition, medical marijuana is a highly controversial area. As an oncologist, I always, I got a frequent questions about use of marijuana or CBD oil. This area clearly for patient with cancer or chemotherapy, they may have other chronic condition, and such as neuropathy, poor appetite. I do see some patient take this medicine on their own or from other providers. This seems help their symptoms. But I also caution my patients this medicine when they are getting active chemotherapy or oral agent. I will caution them as a treating physician, know whether he or she is taking so we can monitor the potential drug-drug interaction to minimize the side-effects for that treatment.